NCT01458080View on ClinicalTrials.gov

WEUSKOP5410: Observational Study in ENABLE Clinical Trials

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Hepatitis C

Interventions

DRUG

eltrombopag

eltrombopag

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01458080 - WEUSKOP5410: Observational Study in ENABLE Clinical Trials | Biotech Hunter | Biotech Hunter